{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/27/3301777/28908/en/Tonix-Pharmaceuticals-Announces-Publication-of-Phase-1-Clinical-Data-of-TNX-1500-an-Fc-Modified-anti-CD40L-CD154-Monoclonal-Antibody-in-the-Peer-Reviewed-Journal-of-Clinical-Immuno.html", "message": "News view counter 757591 successfully enlarged"}